Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:32 PM
Ignite Modification Date: 2025-12-25 @ 8:05 PM
NCT ID: NCT03988335
Description: None
Frequency Threshold: 0
Time Frame: From ICF signature to end of study participation (approximately 73 days)
Study: NCT03988335
Study Brief: A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
RIST4721 300 mg All subjects who received at least one dose of RIST4721 300 mg (Safety Analysis Set). 0 None 0 15 13 15 View
Placebo All subjects who received at least one dose of Placebo (Safety Analysis Set). 0 None 0 19 7 19 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Hepatic enzyme increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (21.1) View
Leukopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (21.1) View
Osteoarthritis SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (21.1) View
Increased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (21.1) View
Folliculitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (21.1) View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA (21.1) View
Anxiety SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (21.1) View
Vaginal haemorrhage SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA (21.1) View
Procedural pain SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (21.1) View
Ligament sprain SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (21.1) View
Concussion SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (21.1) View
Bacterial test SYSTEMATIC_ASSESSMENT Investigations MedDRA (21.1) View
Blood glucose increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (21.1) View
Blood triglycerides increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (21.1) View
Neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (21.1) View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (21.1) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (21.1) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (21.1) View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (21.1) View
Abnormal faeces SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (21.1) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (21.1) View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (21.1) View
Urine odour abnormal SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (21.1) View
Micturition disorder SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (21.1) View
Skin fissures SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (21.1) View
Musculoskeletal stiffness SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (21.1) View
Pain in extremity SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (21.1) View
Myalgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (21.1) View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (21.1) View
Decreased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (21.1) View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (21.1) View
Post procedural cellulitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (21.1) View